Cardiff-headquartered TrakCel, which develops software for cell and gene therapy companies, has appointed a new director (Insider Media, 2017).

Dr Anthony Davies, from Dark Horse Consulting, has been recruited as a non-executive director. He trained as a biochemist, chemical engineer and molecular biologist and has worked in the cell and gene therapy field for more than twenty years. Most recently, he was chief technology officer for Capricor and vice president of product development for Geron Corporation’s cell therapy programmes. At TrakCel, he will provide regulatory consultancy and advice on the company’s processes and governance to contribute to its growth plans.

Ravi Nalliah, chief executive at TrakCel, said “Anthony is a great appointment for us. His strategic advice will be vital in helping us continue to streamline our processes so that we ensure our technology has maximum efficiency for the benefit of our customers.”

Anthony Davies said “TrakCel has made several significant appointments recently and I’m thrilled to join this growing and talented team at a crucial time in the firm’s development. I believe my background and experience in regulatory consultancy will be extremely beneficial in helping the company reach its ambitious growth targets.”